Showing results (161-170 of 189) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|April 6, 2001
Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenograftsF S Kenny, J M Gee, R I Nicholson, et al.
Anticancer Research|May 1, 1997
Male breast cancer: pathological and immunohistochemical featuresP C Willsher, I H Leach, I O Ellis, et al.
Breast Cancer Research and Treatment|December 5, 1997
Predictors of response to second-line endocrine therapy for breast cancerK L Cheung, P C Willsher, S E Pinder, et al.
Anticancer Research|December 17, 1998
C-erbB2 expression predicts response to preoperative chemotherapy for locally advanced breast cancerP C Willsher, S E Pinder, J M Gee, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 1, 1995
The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associationsS E Pinder, P M Wencyk, H E Naylor, et al.
International Journal of Cancer|April 10, 1995
Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5S A Watson, D Michaeli, S Grimes, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
The primary use of endocrine therapiesA Howell, E Anderson, R Blamey, et al.
British Journal of Cancer|January 1, 1995
Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survivalS E Pinder, P Wencyk, D M Sibbering, et al.
British Journal of Cancer|October 1, 1995
Metallothionein expression in human breast cancerH Goulding, B Jasani, H Pereira, et al.
Oncogene|October 27, 1998
c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancerJ M Knowlden, J M Gee, L T Seery, et al.
Pageof 19